NANDROLONE PHENPROPIONATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nandrolone Phenpropionate, and what generic alternatives are available?
Nandrolone Phenpropionate is a drug marketed by Watson Labs and is included in two NDAs.
The generic ingredient in NANDROLONE PHENPROPIONATE is nandrolone phenpropionate. There are fifteen drug master file entries for this compound. Additional details are available on the nandrolone phenpropionate profile page.
Summary for NANDROLONE PHENPROPIONATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 44 |
Patent Applications: | 4,302 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NANDROLONE PHENPROPIONATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for NANDROLONE PHENPROPIONATE
US Patents and Regulatory Information for NANDROLONE PHENPROPIONATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | NANDROLONE PHENPROPIONATE | nandrolone phenpropionate | INJECTABLE;INJECTION | 086386-001 | Jun 17, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | NANDROLONE PHENPROPIONATE | nandrolone phenpropionate | INJECTABLE;INJECTION | 087488-001 | Jun 17, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |